Atara Biotherapeutics, Inc. ($ATRA)
Grant-Huerta Yanina โ Chief Accounting Officer
Shares
24
Price
$5.08
Total Value
$121.85
Nearby Earnings
Mar 6, 2026
EPS:Est: -0.68
Mar 13, 2026
EPS:Est: -0.18
Revenue:Est: $1.63M
Mar 16, 2026
EPS:-0.25 (est: -0.18)+42.1%
Revenue:$1.59M (est: $1.63M)-2.4%
Transaction Details
| Insider | Grant-Huerta Yanina |
|---|---|
| Title | Chief Accounting Officer |
| Transaction Date | Mar 2, 2026 |
| Transaction Code | S Sale |
| Acquired/Disposed | Disposed |
| Security | Common Stock |
| Direct/Indirect | Direct |
| Filing Date | Mar 4, 2026 |
| Shares Sold | 24 |
| Price per Share | $5.08 |
| Total Value | $121.85 |
| Shares Owned After | 33,830 |
| Derivative | No |
| Accession Number | 0000905148-26-001144 |
| Document | View SEC Filing |